125 related articles for article (PubMed ID: 10703730)
1. Nonreceptor interactions in the pharmacology of blood platelets.
Nosál R; Jancinová V
Gen Physiol Biophys; 1999 Oct; 18 Spec No():120-5. PubMed ID: 10703730
[TBL] [Abstract][Full Text] [Related]
2. Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2)).
Nosál R; Jancinová V
Thromb Res; 2002 Feb; 105(4):339-45. PubMed ID: 12031829
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological intervention with platelet phospholipase A2.
Nosal R; Jancinova V
Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties.
Jancinová V; Májeková M; Nosál R; Petríková M
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):191-3. PubMed ID: 8735816
[TBL] [Abstract][Full Text] [Related]
5. [The effect of antihistamines on stimulated blood platelet functions].
Nosál R; Jancinová V; Petríková M
Cesk Fysiol; 1995 Mar; 44(1):21-3. PubMed ID: 7758143
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine: a multipotent inhibitor of human platelets in vitro.
Nosál' R; Jancinová V; Danihelová E
Thromb Res; 2000 Jun; 98(5):411-21. PubMed ID: 10828481
[TBL] [Abstract][Full Text] [Related]
7. The H1-histamine antagonist Dithiaden inhibits human platelets in vitro.
Nosál R; Jancinová V; Danihelová E
Inflamm Res; 1996 Mar; 45 Suppl 1():S29-30. PubMed ID: 8696916
[No Abstract] [Full Text] [Related]
8. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
Schafer AI; Adelman B
J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine inhibits stimulated platelets at the arachidonic acid pathway.
Nosál R; Jancinová V; Petríková M
Thromb Res; 1995 Mar; 77(6):531-42. PubMed ID: 7624839
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester.
Lee GY; Chang TS; Lee KS; Khil LY; Kim D; Chung JH; Kim YC; Lee BH; Moon CH; Moon CK
Thromb Res; 2005; 115(4):309-18. PubMed ID: 15668191
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
Sato T; Nakao K; Hashizume T; Fujii T
Biochim Biophys Acta; 1987 Nov; 931(2):157-64. PubMed ID: 3663714
[TBL] [Abstract][Full Text] [Related]
12. Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide.
Zahavi M; Rozen P; Zahavi J
Thromb Res; 1990 Aug; 59(3):693-9. PubMed ID: 2146767
[No Abstract] [Full Text] [Related]
13. Effect of anethole dithiolthione on human platelet aggregation.
Selley ML; McGuiness JA; Bartlett MR; Ardlie NG
Arzneimittelforschung; 1992 Mar; 42(3):318-21. PubMed ID: 1497692
[TBL] [Abstract][Full Text] [Related]
14. Human polymorphonuclear leukocytes: effect of chloroquine on aggregation, arachidonic acid liberation and thromboxane B2 generation.
Kotuliaková K; Nosál R; Pecivová J; Drábiková K; Macicková T
Gen Physiol Biophys; 1996 Dec; 15(6):489-94. PubMed ID: 9248834
[TBL] [Abstract][Full Text] [Related]
15. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
16. Effects of cryptolepine on collagen-induced aggregation and on the mobilization and metabolism of arachidonic acid by rabbit platelets.
Oyekan AO; Ablordeppey SY
Gen Pharmacol; 1993 Sep; 24(5):1285-90. PubMed ID: 8270188
[TBL] [Abstract][Full Text] [Related]
17. Effect of pyridoxal-5'-phosphate on aggregation of platelets from stored human concentrates induced by arachidonic acid.
Nolan ML; Harrington MG; Eljamil A
Biochem Soc Trans; 1996 Feb; 24(1):95S. PubMed ID: 8674780
[No Abstract] [Full Text] [Related]
18. Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation.
Mounier C; Faili A; Vargaftig BB; Bon C; Hatmi M
Eur J Biochem; 1993 Aug; 216(1):169-75. PubMed ID: 8365403
[TBL] [Abstract][Full Text] [Related]
19. The H1-histamine receptor antagonist dithiaden inhibits stimulated platelet aggregation, malondialdehyde formation and thromboxane production in vitro.
Nosál R; Jancinová V; Petríková M
Inflamm Res; 1995 Apr; 44 Suppl 1():S14-5. PubMed ID: 8520978
[No Abstract] [Full Text] [Related]
20. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
